The frequency of autoantibodies in acquired TTP patients suggesting that an immune‐mediated activity against ADAMTS13 is present in almost all patients presenting with HIV‐associated TTP [22, 27]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.